In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics.

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications ...

FibroMAP combines the power of high-resolution, single-fiber, and spatially resolved datasets generated by PharmaNest's ...

Executing GATC Health's Strategic Vision Dr. Gupta's forward-thinking policies while at the White House delivered a ...

Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic ...

CNSI isn’t really just academia,” said Damoiseaux, director of UCLA’s Molecular Screening Shared Resource. “While a lot of ...

Efficiency and cost-effectiveness are key drivers in these recent developments in AI drug discovery and development, given that R&D for a new drug can take up to 18 years. The overarching desire ...

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

Artificial Intelligence (AI) is no longer a futuristic idea in healthcare; it is reshaping the industry right now, and 2025 ...

Detailed price information for Theralase Technologies Inc (TLTFF) from The Globe and Mail including charting and trades.